Brief: Sol-Gel, Beimei Pharma Announce Asset Purchase Agreement

SOL-GEL TECHNOLOGIES

16/05/2024 11:05

May 16 (Reuters) - Sol Gel Technologies Ltd  SLGL.O :
    * SOL-GEL AND BEIMEI PHARMA ANNOUNCE AN ASSET PURCHASE
AGREEMENT
TO COMMERCIALIZE TWYNEO® IN THE MAINLAND OF CHINA, HONG KONG,
MACAU, TAIWAN AND ISRAEL
    * SOL GEL TECHNOLOGIES LTD: SOL-GEL WILL RECEIVE, UPFRONT
AND
MILESTONE PAYMENTS OF US$10 MILLION AND UP TO US$5 MILLION AS
ROYALTY PAYMENTS ON NET SALES

Source text for Eikon:  ID:nGNX15mmnM 
Further company coverage:  SLGL.O 

 ((Reuters.Briefs@thomsonreuters.com;))